JVMIX
Price
$30.02
Change
-$0.95 (-3.07%)
Updated
Dec 18 closing price
NCAVX
Price
$12.29
Change
-$1.06 (-7.94%)
Updated
Dec 18 closing price
Ad is loading...

JVMIX vs NCAVX

Header iconJVMIX vs NCAVX Comparison
Open Charts JVMIX vs NCAVXBanner chart's image
JHancock Disciplined Value Mid Cap I
Price$30.02
Change-$0.95 (-3.07%)
VolumeN/A
CapitalizationN/A
Nuance Concentrated Value Investor
Price$12.29
Change-$1.06 (-7.94%)
VolumeN/A
CapitalizationN/A
JVMIX vs NCAVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMIX vs. NCAVX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMIX is a Hold and NCAVX is a Hold.

FUNDAMENTALS
Fundamentals
JVMIX has more cash in the bank: 23.4B vs. NCAVX (174M). NCAVX pays higher dividends than JVMIX: NCAVX (1.52) vs JVMIX (0.84). JVMIX was incepted earlier than NCAVX: JVMIX (28 years) vs NCAVX (12 years). NCAVX is a more actively managed with annual turnover of: 67.00 vs. JVMIX (41.00). NCAVX has a lower initial minimum investment than JVMIX: NCAVX (2500) vs JVMIX (250000). JVMIX (11.12) and NCAVX (10.61) have marching annual gain over last year. JVMIX return over 5 years is better than : 42.01 vs. NCAVX (-9.90).
JVMIXNCAVXJVMIX / NCAVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years12 years-
Gain YTD13.1538.225160%
Front LoadN/AN/A-
Min. Initial Investment250000250010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B174M13,448%
Annual Yield % from dividends0.841.5255%
Returns for 1 year11.1210.61105%
Returns for 3 years17.73-13.34-133%
Returns for 5 years42.01-9.90-424%
Returns for 10 years60.931.284,748%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMC4.250.19
+4.68%
AMC Entertainment Holdings
JHX33.690.12
+0.36%
JAMES HARDIE INDUSTRIES plc
AI42.86-0.08
-0.19%
C3ai
CTGO11.20-0.36
-3.11%
Contango ORE
CARA0.25-0.01
-3.22%
Cara Therapeutics